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Abstract
Background: Dietary administration of 1% canavanine had been shown to improve survival in
female BALB/c mice consuming diets containing 23.4% protein (dry matter basis).
Methods: In order to determine if this effect also obtains at more moderate dietary protein
concentrations, 30 female BALB/c mice were fed a basal diet with 14% protein (15.7% dry matter
basis) and another 30 were fed the same diet plus 1% canavanine.
Results: Neither mean (Control 873.2 d, Canavanine 870.0 d; SEM = 34.2 d; P = 0.949 from
ANOVA) nor median (Control 902 d, Canavanine 884.5 d; P = 0.9058 from Mann-Whitney)
lifespans differed between groups.
Although mean antinuclear antibody (ANA) titers did not differ between control and canavanine-
treated mice at 833 days of age (19.84 vs 20.39 respectively; SEM = 2.64; P = 0.889 from ANOVA),
one canavanine-treated mouse displayed an outlying ANA value of 50 (next lower value = 30)
denoting possible early sign of incipient autoimmune disease in that individual.
Conclusion: There may be an interaction between dietary protein level and canavanine with
respect to lifespan in mice.
Background
L-canavanine is a common non-protein amino acid found
naturally in alfalfa sprouts, broad beans, jack beans, and a
number of other legume foods and animal feed ingredi-
ents [1] at up to 2.4% of food dry matter. This analog of
arginine (Figure 1.) can also block NO synthesis [2-5],
interfere with normal ammonia disposal [6,7], charge
tRNAarg, cause the synthesis of canavanyl proteins [8], as
well as prevent normal reproduction in arthropods [9]
and rodents [10].
Canavanine has also been reported to induce a condition
that mimics systemic lupus erythematosus (SLE) in pri-
mates [11,12], to increase antibodies to nuclear compo-
nents and promote SLE-like lesions in auto immune-
susceptible (e.g., (NZB X NZW)F1) mice [13].
In our previous study [14], eighteen female BALB/c mice
were fed a 23.4% protein diet containing 1.56% L-cana-
vanine sulfate (equivalent to 1% L-canavanine base) and
eighteen control mice received control diet (23.4% pro-
tein) from 84–477 days of age. More canavanine-fed mice
(16 of 18) survived to age 477 days than those fed the
basal diet (9 of 18) (X 2 with Yates correction = 24.8).
Published: 25 February 2005
Nutrition & Metabolism 2005, 2:7 doi:10.1186/1743-7075-2-7
Received: 09 December 2004
Accepted: 25 February 2005
This article is available from: http://www.nutritionandmetabolism.com/content/2/1/7
© 2005 Brown; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutrition & Metabolism 2005, 2:7 http://www.nutritionandmetabolism.com/content/2/1/7
Page 2 of 5
(page number not for citation purposes)
The death rate and median life span of control mice were
consistent with previously reported survival studies of
female BALB-C mice fed high protein diets [15]. Necropsy
and histopathology from both experimental animals and
co-housed cages of contemporary sentinel mice per-
formed by the University of California Comparative
Pathology Laboratory (Davis, Ca.) did not detect any sig-
nificant gross or histopathological lesions, parasites or
pathogenic bacteria, viruses or mycoplasma. Serology
results were negative as well. There was no evidence of
infectious disease and no evidence of the lung tumors
often found in older BALB-C mice [15]. One sentinel, but
no experimental animals, showed evidence of a
lymphosarcoma.
Kristal and Yu [16] have suggested that aging "...results in
deleterious changes in cellular, intercellular, tissue and
organismic functions."
Apparently, canavanine postponed the type of physiolog-
ical decline that results in earlier death due to the inability
of these aging mice to maintain homeostasis in the face of
undetectable disease or some other stress.
These were serendipitous findings during a project
designed to explore the mechanism of diet-induced
autoimmunity. Ironically, no positive ANAs or anti
SSDNA or anti dsDNA titers were detected in these mice
as a result of canavanine treatment.
Previous reports of life span extension by restricting the
intake of energy [17], protein [18], tryptophan [19] and
methionine [20] have been accompanied by severe reduc-
tions in growth and eventual body size relative to con-
trols. The severe stunting usually associated with amino
acid deficiency and extended life span was not observed in
the BALBc mice [14].
Our earlier results did leave unanswered the question of
whether canavanine was extending life or merely offset-
ting the life-shortening effects of a very high protein diet.
Since the objectives of the original investigation were
unrelated to lifespan determination and required the har-
vest of body tissues, full lifespan data were not available.
The purpose of the experiment reported here was to test
the hypothesis that canavanine will reduce middle age
mortality and extend the lifespan of female BALB/c mice
consuming a diet containing moderate concentrations of
protein (15.7% DMB).
Methods
Five female 100-day-old 20-gram BALB/cAnHsd mice
(first generation offspring of mice obtained from Harlan
Sprague-Dawley) were assigned to each of twelve cages
and six cages were randomly assigned to each of two treat-
ments: Control = 25 g of ground Agway 1000 lab animal
feed or Canavanine = 25 g of a mixture containing 1.56%
canavanine sulfate (prepared by the method of Rosenthal
[21]) and 98.44% ground Agway 1000 lab animal feed
resulting in a diet containing 1% L-canavanine base
Chemical structure of canavanine and arginine Figure 1
Chemical structure of canavanine and arginine
Table 1: Experimental Diets
Nutrient Basal (Agway 
Prolab 1000)
Basal Diet + 
canavanine
Dry Master % 89.88 89.78
All others on DMBasis
NX6.25 % 15.70 17.84
Lipids % 7.05 6.94
Ash % 6.54 6.44
Gross Energy kcal/g 4.5 4.5
Estimated Metabolizable Energy 
kcal/
3.3 3.3
Calcium % 0.90 0.89
Phosphorus % 0.8 0.79
Arginine % 0.81 0.80
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(Table 1). All animals were weighed monthly for the first
28 months of age and cause of death determined by symp-
toms and necropsy. As animals died, feed offerings were
reduced, but 5 grams per head ratio was maintained.
At 833 days of age, blood samples were taken from the
supraorbital sinus of the 37 surviving mice (19 controls
and 18 canavanine-fed) and analyzed for antinuclear anti-
bodies (ANA) by the methods of Naiki, et al [22].
Variations in lifespan and ANA values were evaluated by
analyses of variance and median values were contrasted
by the Mann Whitney procedure [23].
Results
Neither mean (870.0 vs 873.2, SEM = 34.2) nor median
(885 vs 902, W = 923.5) lifespan differed significantly
between mice fed canavanine and those fed the same
basal diet without canavanine, respectively. (Figure 2).
Although mean (20.39 vs 19.84) indices of ANA titers at
833 days of age were also similar for canavanine and con-
trol treatments, one canavanine-fed mouse displayed an
unusually high titer (10X SEM above mean). (Figure 3).
About half of the mice (48.3%) displayed mammary
tumors, pulmonary adenocarcinomas or both at the time
of death (17 canavanine mice and 12 controls; but the dif-
ference was not significant by Chi-square analysis, [23])
(Table 2). No infectious diseases were detected in either
experimental or sentinel mice.
Discussion
The median longevity of control mice observed in this
experiment (in which a 15.7% protein was fed) consider-
Survival of mice fed 15.7% dietary protein Figure 2
Survival of mice fed 15.7% dietary protein
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ably exceeds that of the previous trial in which the basal
diet contained 23.4% protein (902 d vs 449 d). Storer [24]
fed BALB/c mice a diet of protein content between those
two extremes (17%, but probably closer to 19% on a dry
matter basis) and observed mean longevity for females of
575 d, a result falling between our two observations. That
decreasing protein concentrations should extend rodent
lifespan is not a unique finding, the phenomenon is well
known. The apparent corrective effect of canavanine at
high protein concentrations and lack of effect at more
moderate concentrations does offer a new dimension to
dietary modulation of longevity that bears further study.
Antinuclear Antibodies Figure 3
Antinuclear Antibodies
Table 2: Probable cause of death
Mammary 
Tumor
Pulmonary 
Adenocarcinom
a
Both Types of 
Tumor
Total With Any 
Tumor
Other Undetermined
C a n a v a n i n e 9711 7 21 1
C o n t r o l 6421 2 31 5
X2(Yates) 0.44 0.37 0.56 0.35 0.65 0.43
P >0.50 >0.50 >0.30 >0.50 >0.30 >0.50
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A number of populations consume protein in amounts
that far exceed known nutritional requirements (humans
in some Western countries, alfalfa-fed horses in some
Western States and pet dogs in most of the Northern Hem-
isphere). The impact of these protein intakes on human
and domestic animal longevity and the possible corrective
effects of non-protein amino acids on those effects should
interest a variety of medical, veterinary and nutritional
workers.
For the second time, we have failed to induce significant
autoimmune disease signs with dietary canavanine in
BALB/c mice. Since this can be done in autoimmune sus-
ceptible strains and hybrids and in the "normal" (DBA/2)
strain of mice [13], genetic differences may play a role in
an animal's response to this secondary plant compound.
These preliminary experiments were not contemporary
comparisons, nor were they conducted with both sexes,
with the same source of BALB/c mice, the same basal diets
or at the same locations. Known autoimmune-susceptible
lines were not challenged in those trials. Although the
data from those trials did indicate a canavanine-protein
concentration interaction, we propose a contemporary,
comprehensive, integrated experiment including both
autoimmune susceptible and more normal populations.
The proposed work will be more conclusive and provide
an opportunity to examine the generality of the cana-
vanine longevity effect, suggest mechanisms for its occur-
rence and find out if positive effects on oxidation event-
dependent aging might be offset by autoimmunity in sus-
ceptible individuals. Examination of such indices as tissue
and urine nitrate/nitrite, 8-OH deoxyguanidine, cana-
vanyl residues in specific and total proteins would all con-
tribute to a better understanding of mechanisms of
longevity modulation.
Conclusion
This and a previous study suggest that an interaction
between dietary protein concentration and canavanine
effects on longevity may exist in BALB/c mice. Contempo-
rary trials that vary both protein and canavanine concen-
trations are needed to test this possibility more
conclusively.
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